Evaluating the safety and potential activity of URO‐902 (hMaxi‐K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non‐neurogenic) overactive bladder syndrome and detrusor overactivity from two double‐blind, imbalanced, placebo‐controlled randomized phase 1 trials

AIMS: Two phase 1 trials were performed in healthy women with the overactive bladder (OAB) syndrome and urodynamically demonstrated detrusor overactivity (DO), with the aim to demonstrate the safety and potential efficacy of URO‐902, which comprises a gene therapy plasmid vector expressing the human...

Descripción completa

Detalles Bibliográficos
Autores principales: Rovner, Eric, Chai, Toby C., Jacobs, Sharon, Christ, George, Andersson, Karl‐Erik, Efros, Mitchell, Nitti, Victor, Davies, Kelvin, McCullough, Andrew R., Melman, Arnold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028015/
https://www.ncbi.nlm.nih.gov/pubmed/31945197
http://dx.doi.org/10.1002/nau.24272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028015/
https://www.ncbi.nlm.nih.gov/pubmed/31945197
http://dx.doi.org/10.1002/nau.24272

Ejemplares similares